Search results
Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further...
WTNH-TV New Haven· 8 hours ago...atrasentan is a potent, selective ETA receptor antagonist with potential to reduce persistent...
US pharma giant Cencora says Americans' health information stolen in data breach
TechCrunch· 1 day agoU.S. pharmaceutical giant Cencora says it is notifying affected individuals that their personal and...
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing...
KTLA-TV Los Angeles· 8 hours agoNovartis today presented results from the 6-month, double-blind period of the Phase III APPEAR-C3G study of Fabhalta® (iptacopan) at the late-breaking clinical trials session ...
Novartis to seek approvals in two rare kidney diseases after positive Phase 3 trials
Endpoints News· 8 hours agoNovartis is building out its rare kidney disease portfolio with two batches of Phase 3 data at the...
UBS Group AG Has $167.76 Million Stock Holdings in Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 4 days agoUBS Group AG trimmed its stake in shares of Novartis AG (NYSE:NVS – Free Report) by 9.9% during the fourth quarter, according to its most recent disclosure with the Securities ...
Level Four Advisory Services LLC Cuts Stock Position in Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 5 days agoLevel Four Advisory Services LLC trimmed its holdings in shares of Novartis AG (NYSE:NVS – Free Report) by 5.9% during the 4th quarter, according to the company in its most ...
Novartis Patient Information Leaked in Third-Party Data Breach at Lash Group | JD Supra
JD Supra· 2 days agoIn this notice, Lash Group explains that the incident resulted in an unauthorized party being able to access sensitive information belonging to patients enrolled in “patient support programs ...
Cencora data breach exposes US patient info from 8 drug companies
BleepingComputer· 1 day agoCencora, formerly AmerisourceBergen, is a pharmaceutical services provider specializing in drug...
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information...
Benzinga via AOL· 1 day agoU.S. drug wholesaler Cencora Inc (NYSE:COR), formerly AmerisourceBergen, is notifying affected...
ASCO: J&J's radioligand spurs responses, but 4 deaths mar early results
FierceBiotech· 1 day agoJohnson & Johnson’s radiopharmaceutical spurred “profound and durable” responses, however, four...